Anthos Therapeutics, based in Cambridge, has a drug in late-stage clinical trials aimed at preventing strokes and blood clots.

The acting chair of the, Mark Uyeda, took the first step Tuesday to rolling back a rule that would require thousands of ...

Danielle Rasooly, PhD, of the Division of Aging at Brigham and Women’s Hospital, is the co-corresponding author of a paper published in Nature Cardiovascular Research, “Large-scale multi-omics ...

The federal order temporarily halts the Trump administration’s plans to slash $4 billion in overhead costs for research at ...

These indirect costs are negotiated with each research institution and average close to 30 percent of the amount awarded for ...

In the same year, it also created the Novartis Institutes for BioMedical Research (NIBR), which headquarters in the US. In 2003, Novartis acquired the worldwide adult medical nutrition business of ...

Jay Bradner, president of the Novartis Institutes for Biomedical Research (NIBR), is retiring from the position after seven years in the role, and will be replaced by Merck & Co R&D executive ...

Funding cuts to the National Institutes of Health’s, the United States' leading medical research agency, biomedical research grants may deeply impact Alabama institutions, researchers and residents.

How would you summarize your study for a lay audience?Heart failure remains a substantial burden for patients due to its high ...

President Donald Trump's administration has announced it will slash billions of dollars from overheads in grants for biomedical ... the National Institutes of Health (NIH) said it would cut grants for ...

The Trump administration is cutting billions of dollars in biomedical research ... for scientific research. The move, announced Friday night by the National Institutes of Health, drastically ...